Prevalence of bleeding disorders in women with menorrhagia

Prevalence of bleeding disorders in women with menorrhagia - Menorrhagia and bleeding disorders

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39998

Enrollment

287

Registered

2013-08-12

Start date

2013-09-19

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

heavy menstrual bleeding menorrhagia

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Healthy controls with regular normal menstrual bleeding Age *18 years Written informed consent - Patients with regular heavy menstrual bleeding (

Exclusion criteria

Exclusion criteria: - Healthy controls with: 1. postmenopausal, postcoital or intermenstrual bleeding. 2. an intra-uterine device or hormonal treatment. 3. anticoagulant, antithrombotic therapy or use of non-steroidal anti-inflammatory drugs (NSAIDs). - Patients with: 1. postmenopausal, postcoital or intermenstrual bleeding. 2. an intra-uterine device or hormonal treatment. 3. anticoagulant, antithrombotic therapy or use of non-steroidal anti-inflammatory drugs (NSAIDs).

Design outcomes

Primary

Measure	Time frame
Plasma FXI levels.	—

Secondary

Measure	Time frame
FXI gene mutations/polymorfisms. Prevalence of bleeding disorders in patients with menorrhagia.	—

Countries

Netherlands

Outcome results